Cargando…
Neurological illness following treatment with fludarabine.
Fludarabine is a comparatively new drug for the treatment of low-grade lymphoid malignancy. This report describes five cases of unusual neurological illnesses occurring after treatment with fludarabine. These suggest that caution should be exercised in patients receiving fludarabine who develop neur...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
1994
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033535/ https://www.ncbi.nlm.nih.gov/pubmed/7947105 |
| _version_ | 1782136858691502080 |
|---|---|
| author | Johnson, P. W. Fearnley, J. Domizio, P. Goldin, J. Nagendran, K. Gawler, J. Rohatiner, A. Z. Lister, T. A. |
| author_facet | Johnson, P. W. Fearnley, J. Domizio, P. Goldin, J. Nagendran, K. Gawler, J. Rohatiner, A. Z. Lister, T. A. |
| author_sort | Johnson, P. W. |
| collection | PubMed |
| description | Fludarabine is a comparatively new drug for the treatment of low-grade lymphoid malignancy. This report describes five cases of unusual neurological illnesses occurring after treatment with fludarabine. These suggest that caution should be exercised in patients receiving fludarabine who develop neurological abnormalities, with prompt investigation and if necessary cessation of the drug. IMAGES: |
| format | Text |
| id | pubmed-2033535 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 1994 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-20335352009-09-10 Neurological illness following treatment with fludarabine. Johnson, P. W. Fearnley, J. Domizio, P. Goldin, J. Nagendran, K. Gawler, J. Rohatiner, A. Z. Lister, T. A. Br J Cancer Research Article Fludarabine is a comparatively new drug for the treatment of low-grade lymphoid malignancy. This report describes five cases of unusual neurological illnesses occurring after treatment with fludarabine. These suggest that caution should be exercised in patients receiving fludarabine who develop neurological abnormalities, with prompt investigation and if necessary cessation of the drug. IMAGES: Nature Publishing Group 1994-11 /pmc/articles/PMC2033535/ /pubmed/7947105 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Research Article Johnson, P. W. Fearnley, J. Domizio, P. Goldin, J. Nagendran, K. Gawler, J. Rohatiner, A. Z. Lister, T. A. Neurological illness following treatment with fludarabine. |
| title | Neurological illness following treatment with fludarabine. |
| title_full | Neurological illness following treatment with fludarabine. |
| title_fullStr | Neurological illness following treatment with fludarabine. |
| title_full_unstemmed | Neurological illness following treatment with fludarabine. |
| title_short | Neurological illness following treatment with fludarabine. |
| title_sort | neurological illness following treatment with fludarabine. |
| topic | Research Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033535/ https://www.ncbi.nlm.nih.gov/pubmed/7947105 |
| work_keys_str_mv | AT johnsonpw neurologicalillnessfollowingtreatmentwithfludarabine AT fearnleyj neurologicalillnessfollowingtreatmentwithfludarabine AT domiziop neurologicalillnessfollowingtreatmentwithfludarabine AT goldinj neurologicalillnessfollowingtreatmentwithfludarabine AT nagendrank neurologicalillnessfollowingtreatmentwithfludarabine AT gawlerj neurologicalillnessfollowingtreatmentwithfludarabine AT rohatineraz neurologicalillnessfollowingtreatmentwithfludarabine AT listerta neurologicalillnessfollowingtreatmentwithfludarabine |